Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma

International Journal of Cancer

Volumn 105, Issue 3, 2003, Pages 353-360

  Montuori, Nunzia ^a   Mattiello, Amalia ^b   Mancini, Alessandro ^b   Taglialatela, Paola ^c   Caputi, Mario ^b   Rossi, Guido ^a,c   Ragno, Pia ^a  

^a CNR   (Italy)

^b MONALDI HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Lung cancer; mRNA binding protein; Posttranscriptional regulation; Urokinase; Urokinase receptor

Indexed keywords

MESSENGER RNA; RNA BINDING PROTEIN; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; ENZYME INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0038558477     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11091     Document Type: Article

References (33)

1. Dano K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994;8:189-203
2. Vassalli JD. The urokinase receptor. Fibrinolysis 1994;8:172-81
3. Chapman HA. Plasminogen activators, integrins and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997;9:714-24
4. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA. Regulation of integrin function by the urokinase receptor. Science 1996;273:1551-5
5. Xue W, Mizukami I, Todd III RF, Petty HR. Urokinase-type plasminogen activator receptors associate with beta-1 and beta-3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res 1997;57:1682-9
6. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994;269:32380-8
7. Hoyer-Hansen G, Ronne E, Solberg H, Behrendt N, Ploug M, Lund RL, Ellis V, Dano K. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992;267:18224-9
8. Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J 1997;16:7279-86
9. Ossowskj L, Aguirre-Ghiso JA. Urokinase-receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 2000;12:613-20
10. Blasi F. The urokinase receptor. A cell surface, regulated chemokine. APMIS 1999;107:96-101
11. Casey JR, Petranka JG, Kottra J, Fleenor DE, Rosse WF. The structure of the urokinase-type plasminogen activator receptor gene. Blood 1994;84:1151-6
12. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K, Appella E, Blasi F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 1990;9:467-74
13. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999;56:104-32
14. Lund LR, Ellis V, Ronne E, Pyke C, Dano K. Transcriptional and post-transcriptional regulation of receptor for urokinase-type plasminogen activator by cytokines and tumor promoters in the human lung carcinoma cell line A549. Biochem J 1995;310:345-52
15. Gillis P, Malter JS. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, limphokine, and oncogene mRNAs. J Biol Chem 1991;266:3172-7
16. Rajagopalan LE, Malter JS. Modulation of granulocyte-macrophage colony-stimulating factor mRNA stability in vitro by the adenosine-uridine binding factor. J Biol Chem 1994;269:23882-8
17. Myer VE, Fan XC, Steitz JA. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J 1997;16:2130-9
18. Wang GJ, Collinge M, Blasi F, Pardi R, Bender JR. Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc Natl Acad Sci U S A 1998;95:6296-301
19. Nanbu R, Menoud P-A, Nagamine Y. Multiple instability-regulating sites in the 3′ untranslated region of the urokinase-type plasminogen activator mRNA. Mol Cell Biol 1994;14:4920-8
20. Tillmann-Bogush M, Heaton JH, Gelehrter TD. Cyclic nucleotide regulation of PAI-1 mRNA stability. Identification of cytosolic proteins that interact with an a-rich sequence. J Biol Chem 1999;274:1172-9
21. Maurer F, Tierney M, Medcalf RL. An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type-2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear Hur. Nucleic Acid Res 1999;27:1664-73
22. Yen TJ, Machlin PS, Cleveland DW. Autoregulated instability of beta-tubulin mRNAs by recognition of the nascent amino terminus of beta-tubulin. Nature 1988;334:580-5
23. Wellington CL, Greenberg ME, Belasco JG. The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA. Mol Cell Biol 1993;13:5034-42
24. Yeilding NM, Lee WMF. Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation. Mol Cell Biol 1997;17:2698-707
25. Tierney MJ, Medcalf RL. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs. J Biol Chem 2001;276:13675-84
26. Shetty S, Kumar A, Idell S. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 1997;17:1075-83
27. Montuori N, Salzano S, Rossi G, Ragno P. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor. FEBS Lett 2000;476:166-70
28. Montuori N, Mattiello A, Mancini A, Santoli M, Taglialatela P, Caputi M, Rossi G, Ragno P. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a posttranscriptional mechanism. FEBS Lett 2001;508:379-84
29. Pedersen H, Brunner N, Francis D, Osterlind K, Ronne E, Hansen HH, Dano K, Grondahl-Hansen J. Prognostic impact of urokinase receptor, and plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 1994;54:4671-5
30. Ragno P, Montuori N, Covelli B, Hoyer-Hansen G, Rossi G. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells. Cancer Res 1998;58:1315-9
31. Vassalli JD, Dayer JM, Wohlwend A, Belin D, Concomitant secretion of pro-urokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med 1984;159:1653-68
32. Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000;57:25-40
33. Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M. Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 2000;60:1546-51